Evidence map›Paper›PMID 40512005›Full record

ArticleInfection and immunity2025

Monoclonal antibody neutralizes

Jawad Iqbal, Jessica von Fournier, Nico Wittmann, Murthy N Darisipudi, Daniel M Mrochen, Bojan Smiljanov, Kristin Surmann, Gina Wockenfuß, Leif Steil, Thomas P Kohler and 9 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Infection and immunity, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Jawad Iqbal *Institute of Immunology, University Medicine Greifswald, Greifswald, Germany.
Jessica von Fournier *Institute of Immunology, University Medicine Greifswald, Greifswald, Germany.ORCID 0000-0002-2817-2336
Nico WittmannInstitute of Immunology, University Medicine Greifswald, Greifswald, Germany.
Murthy N DarisipudiInstitute of Immunology, University Medicine Greifswald, Greifswald, Germany.
Daniel M MrochenInstitute of Immunology, University Medicine Greifswald, Greifswald, Germany.
Bojan SmiljanovDepartment of Otorhinolaryngology, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.
Kristin SurmannDepartment of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Greifswald, Germany.
Gina WockenfußDepartment of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Greifswald, Germany.
Leif SteilDepartment of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Greifswald, Germany.
Thomas P KohlerDepartment of Molecular Genetics and Infection Biology, Interfaculty Institute for Genetics and Functional Genomics, Center for Functional Genomics of Microbes, University of Greifswald, Greifswald, Germany.
Felix L GlinkaDepartment of Biotechnology and Enzyme Catalysis, Institute of Biochemistry, University of Greifswald, Greifswald, Germany.
Shruthi PeringatharaInstitute of Immunology, University Medicine Greifswald, Greifswald, Germany.
Christopher SaadeInstitute of Immunology, University Medicine Greifswald, Greifswald, Germany.
Liliane M FernandesInstitute of Immunology, University Medicine Greifswald, Greifswald, Germany.
Uwe BornscheuerDepartment of Biotechnology and Enzyme Catalysis, Institute of Biochemistry, University of Greifswald, Greifswald, Germany.
Christoph A ReichelDepartment of Otorhinolaryngology, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.
Barbara M BrökerInstitute of Immunology, University Medicine Greifswald, Greifswald, Germany.
Dina RaafatInstitute of Immunology, University Medicine Greifswald, Greifswald, Germany.ORCID 0000-0002-3610-9863
Silva HoltfreterInstitute of Immunology, University Medicine Greifswald, Greifswald, Germany.ORCID 0000-0002-2672-8230

Funding

Bundesministerium für Bildung und Forschung InfectControl2020_InVacDeutsche Forschungsgemeinschaft RTG 1870Deutsche Forschungsgemeinschaft RTG 2719EC | EU Social | European Social Fund Plus (ESF) ESF/14-BMA55-0037/16
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antibodies, BacterialAntibodies, MonoclonalAntibodies, NeutralizingBacterial ProteinsSerine ProteasesStaphylococcal InfectionsStaphylococcus aureusAnimalsFemaleHumansMiceMice, Inbred BALB CVirulence FactorsAntibodies, BacterialAntibodies, MonoclonalAntibodies, NeutralizingBacterial ProteinsSerine ProteasesVirulence Factorsantibody characterizationbacterial proteasehost-pathogen interactionneutralizationpassive vaccinationvaccine candidate

Identifiers

PMID40512005
PMCPMC12234435

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.